Timing of Convalescent plasma administration and 28-day mortality for COVID-19 pneumonia
Convalescent plasma administration (CPA) is widely used to treat Covid-19, but its effectiveness remains controversial. Here we report the results of an Expanded Access Program of CPA in the province of Buenos Aires, Argentina. We evaluated the relationship between the timing of CPA and 28-day morta...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Articulo Preprint |
Lenguaje: | Inglés |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/125182 |
Aporte de: |
id |
I19-R120-10915-125182 |
---|---|
record_format |
dspace |
institution |
Universidad Nacional de La Plata |
institution_str |
I-19 |
repository_str |
R-120 |
collection |
SEDICI (UNLP) |
language |
Inglés |
topic |
Ciencias Médicas Covid-19 pneumonia Plasma convalescent Outcome 28-day mortality Early administration |
spellingShingle |
Ciencias Médicas Covid-19 pneumonia Plasma convalescent Outcome 28-day mortality Early administration González, Soledad E. Regairaz, Lorena Salazar, Martín R. Ferrando, Noelia Soledad Gonzalez Martínez, Verónica Ramos, P. Carrera Pesci, Santiago A. Vidal, Juan M. Kreplak, Nicolás Estenssoro, Elisa Timing of Convalescent plasma administration and 28-day mortality for COVID-19 pneumonia |
topic_facet |
Ciencias Médicas Covid-19 pneumonia Plasma convalescent Outcome 28-day mortality Early administration |
description |
Convalescent plasma administration (CPA) is widely used to treat Covid-19, but its effectiveness remains controversial. Here we report the results of an Expanded Access Program of CPA in the province of Buenos Aires, Argentina. We evaluated the relationship between the timing of CPA and 28-day mortality in 4719 hospitalized patients with COVID-19 pneumonia. Early ([≤]3 days from admission) CPA was associated to decreased mortality in patients in the general ward and in the Intensive Care Unit not requiring mechanical ventilation. This suggests that the favorable effect of CPA might be related both to disease acuity and to the therapeutic window. |
format |
Articulo Preprint |
author |
González, Soledad E. Regairaz, Lorena Salazar, Martín R. Ferrando, Noelia Soledad Gonzalez Martínez, Verónica Ramos, P. Carrera Pesci, Santiago A. Vidal, Juan M. Kreplak, Nicolás Estenssoro, Elisa |
author_facet |
González, Soledad E. Regairaz, Lorena Salazar, Martín R. Ferrando, Noelia Soledad Gonzalez Martínez, Verónica Ramos, P. Carrera Pesci, Santiago A. Vidal, Juan M. Kreplak, Nicolás Estenssoro, Elisa |
author_sort |
González, Soledad E. |
title |
Timing of Convalescent plasma administration and 28-day mortality for COVID-19 pneumonia |
title_short |
Timing of Convalescent plasma administration and 28-day mortality for COVID-19 pneumonia |
title_full |
Timing of Convalescent plasma administration and 28-day mortality for COVID-19 pneumonia |
title_fullStr |
Timing of Convalescent plasma administration and 28-day mortality for COVID-19 pneumonia |
title_full_unstemmed |
Timing of Convalescent plasma administration and 28-day mortality for COVID-19 pneumonia |
title_sort |
timing of convalescent plasma administration and 28-day mortality for covid-19 pneumonia |
publishDate |
2021 |
url |
http://sedici.unlp.edu.ar/handle/10915/125182 |
work_keys_str_mv |
AT gonzalezsoledade timingofconvalescentplasmaadministrationand28daymortalityforcovid19pneumonia AT regairazlorena timingofconvalescentplasmaadministrationand28daymortalityforcovid19pneumonia AT salazarmartinr timingofconvalescentplasmaadministrationand28daymortalityforcovid19pneumonia AT ferrandonoeliasoledad timingofconvalescentplasmaadministrationand28daymortalityforcovid19pneumonia AT gonzalezmartinezveronica timingofconvalescentplasmaadministrationand28daymortalityforcovid19pneumonia AT ramospcarrera timingofconvalescentplasmaadministrationand28daymortalityforcovid19pneumonia AT pescisantiagoa timingofconvalescentplasmaadministrationand28daymortalityforcovid19pneumonia AT vidaljuanm timingofconvalescentplasmaadministrationand28daymortalityforcovid19pneumonia AT kreplaknicolas timingofconvalescentplasmaadministrationand28daymortalityforcovid19pneumonia AT estenssoroelisa timingofconvalescentplasmaadministrationand28daymortalityforcovid19pneumonia |
bdutipo_str |
Repositorios |
_version_ |
1764820451348971522 |